Live Breaking News & Updates on University of alabama at birmingham kenneth saag

Study Demonstrates Increased Benefits of Pegloticase and Methotrexate Cotherapy for Uncontrolled Gout

At month 12, response rate was significantly higher in patients receiving pegloticase and methotrexate when compared with concomitant placebo.

Brian-lamoreaux , University-of-alabama-at-birmingham-kenneth-saag , University-of-alabama-at-birmingham , Kenneth-saag , Clinical-immunology ,